Wake Forest Baptist - Comprehensive Cancer Center
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Wake Forest Baptist – Comprehensive Cancer Center
Jun 25, 2024, 13:41 |
Positive
Ruben Mesa: Raising over $4.5M for cancer research over the past 20 years
Ruben Mesa shared on LinkedIn: "Keep Pounding! Amazing event with over 1700 runners from Atrium…
Jun 24, 2024, 21:53 |
Blog
Ruben Mesa: Myeloma community program by International Myeloma Foundation and our amazing Levine Cancer Myeloma team
Ruben Mesa shared a post on X: . “Queen City Myeloma community program…
Jun 15, 2024, 16:54 |
Blog
Our ongoing series “Current Thinking in Myelofibrosis” received The Spring 2024 Digital Health Award - PeerDirect
Ruben Mesa shared the following post by PeerDirect on LinkedIn: “So honored to have taken part…
May 30, 2024, 02:01 |
Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
Feb 27, 2024, 05:06 |
Blog
Ruben Mesa: Huge congratulations to our amazing BMT Program Director and Deputy Chief Clinical Officer Dianna S Howard for her impact and advocacy
Ruben Mesa, President of Atrium Health, shared a post by ASTCT on X/Twitter, adding: “Huge…
Feb 5, 2024, 23:01 |
Blog
Wei Zhang: Cancer Equity Research has been a top priority in our precision oncology initiative for the past 8 years
Wei Zhang, Director at the Center for Cancer Genomics and Precision Oncology, shared on LinkedIn:…
Jan 22, 2024, 18:14 |
Blog
Ruben Mesa: An awesome 1 year anniversary “surprise” cherry pie
Quoting Ruben Mesa, President at Atrium Health Levine Cancer, on X/Twitter: “An awesome 1 year…
All:
7
Posts:
1 - 10
Career Journey to President and CEO - OncoInfluencers
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Facebook
RSS Feed
Twitter
Linkedin
Youtube